Drug Shortage Report for SUPEUDOL 5
| Report ID | 238345 |
| Drug Identification Number | 00789739 |
| Brand name | SUPEUDOL 5 |
| Common or Proper name | SUPEUDOL 5 |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYCODONE HYDROCHLORIDE |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100TAB |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-09-23 |
| Estimated end date | 2025-05-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.